WallStreetZenWallStreetZen

NASDAQ: ABVX
Abivax Sa Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Abivax Sa revenue was N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $1.1M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ABVX annual revenue was $13.0M, with 152.6% growth year-over-year.

ABVX revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when ABVX announces revenue.

ABVX Revenue History By Year

ABVX Yearly RevenueABVX RevenueABVX ChangeABVX Revenue Growth
2024-12-31$12.97M$7.83M+152.56%
2023-12-31$5.13M$258.91k+5.31%
2022-12-31$4.88M-$8.72M-64.13%
2021-12-31$13.59MN/AN/A

1 of 1

Abivax Sa Revenue FAQ

What was ABVX's revenue last quarter?

On Invalid Date, Abivax Sa (NASDAQ: ABVX) reported Q1 2025 revenue of $1.08 million up 16.19% year over year. In the same quarter last year, Abivax Sa's revenue was $1.29 million.

What was Abivax Sa's revenue in 2024?

Abivax Sa's annual revenue for the twelve months ending Dec 31, 2024 was $12.97 million, a 152.56% increase year over year.

How much does Abivax Sa make in a day?

Based on Abivax Sa annual revenue for the past three years, ABVX makes an average of $20,984.19 per day.

What was Abivax Sa's annual revenue growth in the past year?

As of Q3 2025, Abivax Sa's revenue has grown null year over year. Abivax Sa's revenue in the past year totaled N/A.

How much does Abivax Sa make in a year?

Abivax Sa's revenue by year for the past three years is:
  • Abivax Sa's revenue for the twelve months ending Dec 31, 2024 was $12.97 million, a 152.56% increase year over year.
  • Abivax Sa's annual revenue for Dec 31, 2023 was $5.13 million, a 5.31% increase from 2022.
  • Abivax Sa's annual revenue for 2022 was $4.88 million, a 64.13% decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.